IP Library Granted Patent US 10,358,632
Granted Patent B2
US 10,358,632 · App. 15/372,327 · Granted Jul 23, 2019

Bacterial cytochrome P450 protein variant and method of reducing concentration of fluorinated methane in sample using the same

Inventors: Yukyung Jung (Hwaseong-si, KR); Dongsik Yang (Hwaseong-si, KR); Jinhwan Park (Suwon-si, KR); Taeyong Kim (Daejeon, KR); Changduk Kang (Gwacheon-si, KR); Anirban Bhaduri (Bangalore, IN); Tadi Venkata Siva Kumar (Bangalore, IN)
Assignee: SAMSUNG ELECTRONICS CO., LTD.
C12N9/0077B01D53/84B01D53/85C02F3/342C02F3/348C12N9/0006C12N9/0071C12N15/70C12Y101/01049C12Y114/14001C12Y114/15001B01D53/70B01D2251/95B01D2257/2066C02F3/02C02F3/28C02F2101/36Y02W10/12Y02W10/15
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,358,632
App. No.
15/372,327
Granted
Jul 23, 2019
Kind
B2
Abstract

Provided is a recombinant microorganism including an exogenous gene encoding a bacterial cytochrome P450 protein or a variant thereof, a composition including the recombinant P450 protein or the variant thereof, which is used for removing CH n F 4-n (n is an integer of 0 to 3) in a sample, and a method of reducing a concentration of CH n F 4-n in the sample.

Claims (31)

1. A bacterial P450Cam variant polypeptide having an amino acid alteration at an amino acid residue corresponding to position F351 of SEQ ID NO: 6 selected from the group consisting of F351T, F351N, F351Q, and F351D and having an activity belonging to EC 1.14.15.1.

2. The variant polypeptide of claim 1 , wherein the variant polypeptide comprises a P450Cam variant comprising SEQ ID NO: 6 with a substitution at position F351 of SEQ ID NO: 6, wherein the substitution is F351T, F351N, F351Q, or F351D.

3. A composition comprising the P450Cam variant of claim 1 .

4. A polynucleotide encoding the bacterial P450Cam variant polypeptide of claim 1 .

5. A recombinant microorganism comprising an exogenous gene encoding the bacterial P450Cam variant polypeptide of claim 1 .

6. The recombinant microorganism of claim 5 , wherein the exogenous gene encodes a P450Cam variant polypeptide comprising SEQ ID NO: 6 with a substitution at position F351 of SEQ ID NO: 6, wherein the substitution is F351T, F351N, F351Q, or F351D.

7. The recombinant microorganism of claim 5 , further comprising an exogenous gene encoding a protein having an activity belonging to EC 1.1.1.49.

8. A method of reducing a concentration of fluorinated methane in a sample, the method comprising contacting a recombinant P450 protein, or a P450Cam variant polypeptide having an amino acid alteration at an amino acid residue corresponding to position F351 of SEQ ID NO: 6 and having an activity belonging to EC 1.14.15.1, with the sample comprising fluorinated methane represented by CH n F4-n (n is an integer of 0 to 3) to reduce the concentration of fluorinated methane in the sample.

9. The method of claim 8 , wherein the contacting is performed in a sealed container.

10. A method of reducing a concentration of fluorinated methane in a sample, the method comprising contacting a recombinant microorganism with the sample comprising fluorinated methane represented by CH n F4-n (n is an integer of 0 to 3) to reduce the concentration of fluorinated methane in the sample, wherein the recombinant microorganism comprises an exogenous gene encoding a bacterial P450 protein or a variant thereof, wherein the variant is a P450Cam variant having an amino acid alteration at an amino acid residue corresponding to position F351 of SEQ ID NO: 6 and having an activity belonging to EC 1.14.15.1.

11. The method of claim 10 , wherein the contacting is performed in a sealed container where the recombinant microorganism survives or is viable.

12. The method of claim 10 , wherein the contacting comprises culturing the recombinant microorganism in the presence of the sample.

13. The method of claim 10 , wherein the sample is industrial waste water or waste gas.

14. The method of claim 10 , wherein the recombinant microorganism further comprises an exogenous gene encoding a protein having an activity belonging to EC 1.1.1.49.

15. The method of claim 10 , wherein the recombinant microorganism comprises an exogenous gene encoding the P450Cam variant comprising a F351Y, F351T, F351N, F351Q, F351H, or F351D mutation.

16. A bacterial P450BM3 variant polypeptide having an amino acid alteration at an amino acid residue corresponding to position N320 of SEQ ID NO: 8 and having an activity belonging to EC 1.14.14.1.

17. The variant polypeptide of claim 16 , wherein the variant polypeptide comprises a P450BM3 variant comprising SEQ ID NO: 8 with a substitution at position N320.

18. The composition of claim 17 , wherein the substitution at amino acid position N320 is a N320W, N320F, N320G, N320P, N320S, or N320E mutation.

19. A composition comprising the P450BM3 variant polypeptide of claim 16 .

20. A polynucleotide encoding the bacterial P450BM3 variant polypeptide of claim 16 .

21. A recombinant microorganism comprising an exogenous gene encoding the bacterial P450BM3 variant polypeptide of claim 16 .

22. The recombinant microorganism of claim 21 , wherein the exogenous gene encodes a P450BM3 variant polypeptide comprising SEQ ID NO: 8 with a substitution at position N320.

23. The recombinant microorganism of claim 22 , wherein the substitution at position N320 is N320W, N320F, N320G, N320P, N320S, or N320E.

24. The recombinant microorganism of claim 21 , further comprising an exogenous gene encoding a protein having an activity belonging to EC 1.1.1.49.

25. A method of reducing a concentration of fluorinated methane in a sample, the method comprising contacting a P450BM3 variant polypeptide of claim 16 with the sample comprising fluorinated methane represented by CHnF4-n (n is an integer of 0 to 3) to reduce the concentration of fluorinated methane in the sample.

26. The method of claim 25 , wherein the contacting is performed in a sealed container.

27. A method of reducing a concentration of fluorinated methane in a sample, the method comprising contacting the recombinant microorganism of claim 21 with a sample comprising fluorinated methane represented by CHnF4-n (n is an integer of 0 to 3) to reduce the concentration of fluorinated methane in the sample.

28. The method of claim 27 , wherein the contacting is performed in a sealed container where the recombinant microorganism survives or is viable.

29. The method of claim 27 , wherein the contacting comprises culturing the recombinant microorganism in the presence of the sample.

30. The method of claim 27 , wherein the sample is industrial waste water or waste gas.

31. The method of claim 27 , wherein the recombinant microorganism further comprises an exogenous gene encoding a protein belonging to EC 1.1.1.49.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 15, 2016
From: JUNG, YUKYUNG; YANG, DONGSIK; PARK, JINHWAN; KIM, TAEYONG; KANG, CHANGDUK; BHADURI, ANIRBAN; SIVA KUMAR, TADI VENKATA
To: SAMSUNG ELECTRONICS CO., LTD.
Reel/Frame 040944/0098 →
Priority Claims (5)
KR 10-2015-0173293 · Dec 7, 2015 · national
KR 10-2016-0048960 · Apr 21, 2016 · national
KR 10-2016-0075831 · Jun 17, 2016 · national
KR 10-2016-0109543 · Aug 26, 2016 · national
KR 10-2016-0109544 · Aug 26, 2016 · national
Continuity (1)
Related Publication 20170159030A1 · Jun 8, 2017